{"id":226310,"date":"2025-12-02T08:17:32","date_gmt":"2025-12-02T14:17:32","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/12\/beyond-the-buzz-tumor-treating-fields-for-cancer"},"modified":"2025-12-02T08:17:32","modified_gmt":"2025-12-02T14:17:32","slug":"beyond-the-buzz-tumor-treating-fields-for-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/12\/beyond-the-buzz-tumor-treating-fields-for-cancer","title":{"rendered":"Beyond the Buzz: Tumor Treating Fields for Cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/beyond-the-buzz-tumor-treating-fields-for-cancer2.jpg\"><\/a><\/p>\n<p>Tumor-treating fields (TTFields) are gaining traction as evidence expands beyond early enthusiasm, Medscape reports. Once considered experimental, TTFields are now supported by multiple randomized trials and are being tested across a growing list of solid tumors, positioning the therapy as a potential addition to standard cancer care in selected patients.<\/p>\n<hr>\n<p>Here\u2019s a look at how it works, the body of evidence, and the limitations.<\/p>\n<p>Tumor treating fields use low <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7664989\/\" rel=\"nofollow\" target=\"_blank\">intensity, alternating electric fields<\/a> to disrupt cancer cell division.<\/p>\n<p>The electric fields are generated by a wearable device \u2014 Optune Gio for glioblastoma and Optune Lua for pleural mesothelioma and NSCLC \u2014 developed and marketed by Switzerland-based oncology company <a href=\"https:\/\/www.novocure.com\/\" rel=\"nofollow\" target=\"_blank\">Novocure<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tumor-treating fields (TTFields) are gaining traction as evidence expands beyond early enthusiasm, Medscape reports. Once considered experimental, TTFields are now supported by multiple randomized trials and are being tested across a growing list of solid tumors, positioning the therapy as a potential addition to standard cancer care in selected patients. Here\u2019s a look at how [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1977],"tags":[],"class_list":["post-226310","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-wearables"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/226310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=226310"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/226310\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=226310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=226310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=226310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}